Qu Biologics
Restores innate immune function and reverse the chronic inflammation underlying many conditions such as cancer and immune-related disease.
Launch date
Employees
Market cap
-
Enterprise valuation
€44—65m (Dealroom.co estimates Mar 2022.)
Vancouver British Columbia (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | - | |
| N/A | $2.8m | Grant | |
* | N/A | $12.0m | Early VC |
* | $6.7m | Grant | |
* | CAD400k | Grant | |
| Total Funding | €31.5m | ||
Related Content
Recent News about Qu Biologics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.